idazoxan has been researched along with oxidopamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (22.58) | 18.7374 |
| 1990's | 13 (41.94) | 18.2507 |
| 2000's | 5 (16.13) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, M; Saito, H; Smith, CB; Togashi, H; Yoshioka, M | 1 |
| Cervo, L; Samanin, R | 1 |
| Butcher, SP; Clark, AJ; Winn, P | 1 |
| Cervo, L; Grignaschi, G; Samanin, R | 1 |
| Atgie, C; Carpene, C; Lafontan, M; Quideau, N; Saulnier-Blache, JS | 1 |
| Bengzon, J; Brundin, P; Kokaia, M; Lindvall, O | 1 |
| Couture, R; Laneuville, O; Reader, TA | 1 |
| Bengzon, J; Kalén, P; Kokaia, M; Lindvall, O | 1 |
| Curet, O; de Montigny, C | 1 |
| Puurunen, J | 1 |
| Folkow, B; Nilsson, H; Sjöblom, N | 1 |
| Howe, BB; Keith, RA; Salama, AI | 1 |
| Langer, SZ; Pimoule, C; Scatton, B | 1 |
| Kemmotsu, O; Matsumoto, M; Numazawa, R; Saito, H; Togashi, H; Yoshioka, M | 1 |
| Goodwin, WB; Guyenet, PG; Huangfu, D | 1 |
| Beleslin, DB; Jovanović-Mićić, D; Samardzić, R | 1 |
| Legrand, C; Maltier, JP; Mhaouty, S; Rigolot, C | 1 |
| Hirokami, M; Ikeda, T; Matsumoto, M; Saito, H; Smith, CB; Tochihara, M; Togashi, H; Yoshioka, M | 1 |
| Cervo, L; Rossi, C; Samanin, R | 1 |
| Chopin, P; Colpaert, FC; Marien, M | 1 |
| Illes, P; Poelchen, W; Sieler, D; Wirkner, K | 1 |
| Schmidt, WJ; Srinivasan, J | 3 |
| Honda, M; Kino, Y; Ono, H; Tanabe, M | 1 |
| Buck, K; Ferger, B | 1 |
| Buck, K; Ferger, B; Voehringer, P | 1 |
| Barnum, CJ; Bhide, N; Bishop, C; Goldenberg, AA; Klioueva, A; Lindenbach, D; Surrena, MA; Tignor, S; Walters, H | 1 |
| Gerlach, M; Halley, P; Riederer, P; van den Buuse, M | 1 |
| Benazzouz, A; Cardoit, L; Delaville, C; Zapata, J | 1 |
| Huang, C; Liu, J; Wang, HS; Wang, T; Wang, Y | 1 |
31 other study(ies) available for idazoxan and oxidopamine
| Article | Year |
|---|---|
Alpha 2-adrenoceptor modulation of 5-HT biosynthesis in the rat brain.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Clonidine; Dioxanes; Idazoxan; Male; Norepinephrine; Oxidopamine; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Serotonin; Tryptophan | 1992 |
Clonidine causes antidepressant-like effects in rats by activating alpha 2-adrenoceptors outside the locus coeruleus.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Clonidine; Desipramine; Dioxanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Hydroxydopamines; Idazoxan; Locus Coeruleus; Male; Neurons; Norepinephrine; Oxidopamine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1991 |
Evidence for functional separation of alpha-1 and alpha-2 noradrenaline receptors by pre-synaptic terminal re-uptake mechanisms.
Topics: Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Cocaine; Dioxanes; Eating; Hydroxydopamines; Idazoxan; In Vitro Techniques; Male; Microinjections; Nerve Endings; Norepinephrine; Oxidopamine; Paraventricular Hypothalamic Nucleus; Phentolamine; Rats; Receptors, Adrenergic, alpha; Synapses | 1991 |
Alpha 2-adrenoceptor blockade prevents the effect of desipramine in the forced swimming test.
Topics: Adrenergic alpha-Antagonists; Animals; Buspirone; Depression; Desipramine; Dioxanes; Hydroxydopamines; Idazoxan; Locus Coeruleus; Male; Motor Activity; Oxidopamine; Rats; Swimming | 1990 |
Hamster adipocyte alpha 2-adrenoceptor changes during fat mass modifications are not directly dependent on adipose tissue norepinephrine content.
Topics: Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cricetinae; Dioxanes; Energy Intake; Food Deprivation; Hydroxydopamines; Idazoxan; Lipolysis; Male; Mesocricetus; Norepinephrine; Oxidopamine; Pindolol; Quinoxalines; Receptors, Adrenergic, alpha; Sympathectomy, Chemical | 1990 |
Seizure suppression in kindling epilepsy by intrahippocampal locus coeruleus grafts: evidence for an alpha-2-adrenoreceptor mediated mechanism.
Topics: Adrenergic beta-Antagonists; Animals; Dioxanes; Dopamine beta-Hydroxylase; Epilepsy; Hippocampus; Hydroxydopamines; Idazoxan; Kindling, Neurologic; Locus Coeruleus; Male; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Reference Values; Seizures; Transplantation, Heterotopic | 1990 |
Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Biogenic Monoamines; Bradykinin; Catecholamines; Catheters, Indwelling; Dioxanes; Endorphins; Hydroxydopamines; Idazoxan; Injections, Spinal; Kallidin; Male; Naloxone; Oxidopamine; Phentolamine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Reaction Time; Spinal Cord; Yohimbine | 1989 |
Noradrenergic mechanisms in hippocampal kindling with rapidly recurring seizures.
Topics: Adrenergic alpha-Antagonists; Animals; Dioxanes; Electric Stimulation; Hippocampus; Hydroxydopamines; Idazoxan; Kindling, Neurologic; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Seizures | 1989 |
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine.
Topics: Action Potentials; Animals; Dioxanes; Electric Stimulation; Hippocampus; Hydroxydopamines; Idazoxan; Locus Coeruleus; Male; Norepinephrine; Oxidopamine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1988 |
Role of putative neurotransmitters in the central gastric antisecretory effect of prostaglandin E2 in rats.
Topics: 5,6-Dihydroxytryptamine; Adrenergic alpha-Antagonists; Animals; Dinoprostone; Dioxanes; Female; Fenclonine; Gastric Juice; Histamine Antagonists; Hydroxydopamines; Idazoxan; Injections, Intraventricular; Male; Naloxone; Neurotransmitter Agents; Oxidopamine; Phentolamine; Propranolol; Prostaglandins E; Rats; Rats, Inbred Strains; Sulpiride; Theophylline | 1985 |
Interaction between prejunctional alpha 2-receptors and neuronal transmitter reuptake in small mesenteric arteries from the rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzofurans; Cocaine; Dioxanes; Electric Stimulation; Hydroxydopamines; Idazoxan; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Denervation; Muscle, Smooth, Vascular; Neuromuscular Junction; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Vascular Resistance; Yohimbine | 1985 |
Modulation of peripheral beta-1 and alpha-2 receptor sensitivities by the administration of the tricyclic antidepressant, imipramine, alone and in combination with alpha-2 antagonists to rats.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Dioxanes; Heart Rate; Hydroxydopamines; Idazoxan; Imipramine; In Vitro Techniques; Isoproterenol; Male; Oxidopamine; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1986 |
[3H]RX 781094: a new antagonist ligand labels alpha 2-adrenoceptors in the rat brain cortex.
Topics: Adrenergic alpha-Antagonists; Animals; Benzylamines; Binding, Competitive; Cerebral Cortex; Dioxins; Hydroxydopamines; Idazoxan; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Reserpine | 1983 |
Pharmacological characterization of alpha 2-adrenoceptor regulated serotonin release in the rat hippocampus.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Brimonidine Tartrate; Dioxanes; GTP-Binding Proteins; Hippocampus; Idazoxan; Imidazoles; Male; Oxidopamine; Pertussis Toxin; Potassium; Quinoxalines; Rats; Rats, Wistar; Second Messenger Systems; Serotonin; Tetrodotoxin; Virulence Factors, Bordetella | 1995 |
Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats.
Topics: Adrenergic alpha-Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Baclofen; Blood Pressure; Brain Mapping; Desipramine; Dioxanes; Fluoxetine; gamma-Aminobutyric Acid; Idazoxan; Imidazoles; Male; Medulla Oblongata; Microinjections; Nordefrin; Oxidopamine; Rats; Rats, Sprague-Dawley; Splanchnic Nerves; Sympatholytics; Time Factors | 1995 |
The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atropine; Cats; Cerebral Ventricles; Dioxanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hemicholinium 3; Idazoxan; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Naloxone; Oxidopamine; Prazosin; Reserpine; Tolazoline; Tyrosine 3-Monooxygenase; Vomiting; Yohimbine | 1995 |
Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
Topics: Adrenergic alpha-Antagonists; Animals; Autoradiography; Binding, Competitive; Dioxanes; Female; Idazoxan; Kinetics; Microscopy; Myometrium; Oxidopamine; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Tritium; Yohimbine | 1993 |
Inhibitory effects of clonidine on serotonergic neuronal activity as measured by cerebrospinal fluid serotonin and its metabolite in anesthetized rats.
Topics: Adrenergic alpha-Antagonists; Animals; Central Nervous System; Chromatography, High Pressure Liquid; Clonidine; Dioxanes; Idazoxan; Male; Oxidopamine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists | 1993 |
Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Behavior, Animal; Clonidine; Conditioning, Psychological; Dextroamphetamine; Dioxanes; Drug Interactions; Idazoxan; Injections, Intraperitoneal; Locus Coeruleus; Male; Oxidopamine; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 1993 |
Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Behavior, Animal; Benzofurans; Brimonidine Tartrate; Clonidine; Dopamine Agonists; Idazoxan; Imidazoles; Ligands; Male; Methylphenidate; Oxidopamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Stereoisomerism; Stereotyped Behavior; Substantia Nigra | 1999 |
Co-transmitter function of ATP in central catecholaminergic neurons of the rat.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Catecholamines; Electric Stimulation; Evoked Potentials; Excitatory Postsynaptic Potentials; Guanethidine; Idazoxan; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Neurons; Norepinephrine; Oxidopamine; Picrotoxin; Pons; Pyridoxal Phosphate; Rats; Rats, Wistar; Synaptic Transmission; Thionucleotides | 2001 |
The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Topics: Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Brain; Catalepsy; Disease Models, Animal; Dopamine; Exploratory Behavior; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2004 |
Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Drug Interactions; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Statistics, Nonparametric | 2004 |
Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Dextroamphetamine; Drug Synergism; Idazoxan; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Serotonin; Sympatholytics | 2005 |
Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes.
Topics: 5,6-Dihydroxytryptamine; Adrenergic Agents; Adrenergic alpha-Antagonists; Animals; Benzofurans; Clonidine; Dose-Response Relationship, Drug; Idazoxan; Imidazoles; Imidazoline Receptors; Male; Muscle Relaxants, Central; Norepinephrine; Oxidopamine; Rats; Rats, Wistar; Receptors, Drug; Reflex, Monosynaptic; Serotonin; Serotonin Agents; Spinal Cord; Sympathetic Nervous System; Time Factors | 2005 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Brain; Cerebrospinal Fluid; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Plasma; Propranolol; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Tetralones | 2010 |
The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Microdialysis; Neurotoxicity Syndromes; Oxidopamine; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2010 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, Animal; Corpus Striatum; Desipramine; Disease Models, Animal; Dyskinesia, Drug-Induced; Hippocampus; Idazoxan; Levodopa; Male; Molecular Targeted Therapy; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Propranolol; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sympathectomy, Chemical | 2012 |
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antiparkinson Agents; Benserazide; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Facial Asymmetry; Idazoxan; Levodopa; Locomotion; Oxidopamine; Parkinson Disease; Piribedil; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Statistics, Nonparametric; Upper Extremity | 2013 |
Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing.
Topics: Action Potentials; Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic Neurons; Animals; Disease Models, Animal; Exploratory Behavior; Idazoxan; Male; Motor Activity; Movement Disorders; Oxidopamine; Rats; Receptors, Adrenergic, alpha-2; Subthalamic Nucleus; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2012 |
L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Benzylamines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Microdialysis; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 2014 |